Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?
Rebecca Webster(King's College London), Jeremy Howick(University of Oxford), Vitaly Napadow(Spaulding Rehabilitation Hospital), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Andrea W.M. Evers(Leiden University), Sarah E Lamb(University of Exeter), Felicity L. Bishop(University of Southampton), Amy Price(Dartmouth Institute for Health Policy and Clinical Practice), Helen Macdonald, J. André Knottnerus(Maastricht University), Jonathan Rees(Nuffield Orthopaedic Centre), Tammy Hoffmann(Bond University), Claire Madigan(The University of Sydney)
Cited by 26
Related Papers
The psychological impact of quarantine and how to reduce it: rapid review of the evidence
|The Lancet|2020|16.3k
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
|PLoS Medicine|2014|2k
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017
|Annals of the Rheumatic Diseases|2020|1.7k